Alflutinib Uses, Dosage, Side Effects and more

Alflutinib is under investigation in clinical trial NCT03452592 (Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients With T790M).

Trade Name Alflutinib
Generic Alflutinib
Type
Formula C28H31F3N8O2
Weight Average: 568.605
Monoisotopic: 568.252206759
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share